HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alessandro Mathieu Selected Research

Arthritis (Polyarthritis)

1/2022Long-term glucocorticoid treatment and high relapse rate remain unresolved issues in the real-life management of polymyalgia rheumatica: a systematic literature review and meta-analysis.
11/2019Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course.
11/2017Recommendations for the use of biologics and other novel drugs in the treatment of psoriatic arthritis: 2017 update from the Italian Society of Rheumatology.
1/2015Current perspective on the role of the interleukin-23/interleukin-17 axis in inflammation and disease (chronic arthritis and psoriasis).
11/2013The arthritis-associated HLA-B*27:05 allele forms more cell surface B27 dimer and free heavy chain ligands for KIR3DL2 than HLA-B*27:09.
9/2011Etanercept in spondyloarthropathies. Part I: current evidence of efficacy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alessandro Mathieu Research Topics

Disease

16Ankylosing Spondylitis
03/2021 - 05/2003
10Rheumatoid Arthritis
04/2021 - 09/2011
9Systemic Lupus Erythematosus (Libman-Sacks Disease)
03/2021 - 08/2002
8Psoriatic Arthritis
03/2021 - 01/2011
6Arthritis (Polyarthritis)
01/2022 - 09/2011
6Infections
11/2019 - 09/2003
5Spondylarthropathies
09/2011 - 03/2003
4Necrosis
03/2017 - 09/2011
4Autoimmune Diseases (Autoimmune Disease)
01/2017 - 05/2008
3Myositis (Idiopathic Inflammatory Myopathies)
10/2022 - 07/2016
3Inflammation (Inflammations)
01/2020 - 01/2015
3Adult-Onset Still's Disease
01/2020 - 01/2017
3Malaria
01/2019 - 05/2008
3Central Nervous System Lupus Vasculitis
01/2017 - 05/2003
3Systemic Scleroderma (Systemic Sclerosis)
11/2011 - 01/2007
2Virus Diseases (Viral Diseases)
11/2019 - 09/2016
2Hepatitis B
10/2017 - 01/2016
2Multiple Sclerosis
01/2017 - 11/2011
2Psoriasis (Pustulosis Palmaris et Plantaris)
11/2015 - 01/2015
2Vitamin D Deficiency
11/2011 - 09/2009
2Lupus Nephritis
12/2004 - 08/2002
1Neoplasms (Cancer)
10/2022
1Skin Manifestations
10/2022
1Inclusion Body Myositis
10/2022
1Calcinosis
10/2022
1Dermatomyositis (Dermatopolymyositis)
10/2022
1Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis)
01/2022
1Rheumatic Diseases (Rheumatism)
03/2021
1Behcet Syndrome (Behcet's Syndrome)
11/2020
1Vasculitis (Vasculitides)
01/2020
1Interstitial Lung Diseases (Interstitial Lung Disease)
11/2019
1Antisynthetase syndrome
11/2019
1Liver Diseases (Liver Disease)
11/2019
1Neonatal Systemic lupus erythematosus
01/2019
1Exanthema (Rash)
01/2019
1Congenital heart block
01/2019
1Spondylitis
11/2017
1Transverse Myelitis (Necrotizing Myelitis)
03/2017
1Latent Tuberculosis
08/2016
1Tuberculosis (Tuberculoses)
08/2016
1Chronic Hepatitis (Chronic Active Hepatitis)
01/2016
1Dyslipidemias (Dyslipidemia)
06/2015
1Chronic Disease (Chronic Diseases)
01/2015
1Anterior Uveitis
07/2014
1Crohn Disease (Crohn's Disease)
07/2014

Drug/Important Bio-Agent (IBA)

11HLA-B27 Antigen (HLA B27 Antigen)IBA
11/2019 - 05/2003
9AntibodiesIBA
10/2022 - 05/2003
5AutoantibodiesIBA
10/2022 - 08/2007
4Prostaglandins AIBA
11/2020 - 05/2011
4Biological ProductsIBA
11/2019 - 01/2011
4DNA (Deoxyribonucleic Acid)IBA
11/2017 - 08/2007
4HLA-B Antigens (HLA-B)IBA
09/2016 - 08/2007
4HLA-B*27:09 antigenIBA
01/2012 - 03/2003
3Proteins (Proteins, Gene)FDA Link
10/2022 - 01/2006
3Pharmaceutical PreparationsIBA
01/2020 - 01/2017
3AntigensIBA
12/2019 - 03/2009
3Antiviral Agents (Antivirals)IBA
11/2019 - 01/2016
3HLA-B*27:05 antigenIBA
09/2016 - 03/2009
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2016 - 07/2014
3Etanercept (Enbrel)FDA Link
09/2011 - 01/2011
2Ligases (Synthetase)IBA
10/2022 - 11/2019
2Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
01/2020 - 01/2019
2Interleukin-1 (Interleukin 1)IBA
01/2020 - 01/2017
2EpitopesIBA
11/2019 - 09/2016
2Tumor Necrosis Factor InhibitorsIBA
10/2018 - 01/2016
2Biomarkers (Surrogate Marker)IBA
11/2017 - 09/2012
2Certolizumab PegolFDA Link
11/2015 - 04/2014
2Interleukin-23 (Interleukin 23)IBA
01/2015 - 07/2012
2Vitamin DFDA LinkGeneric
11/2011 - 09/2009
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
12/2004 - 08/2002
1RNA (Ribonucleic Acid)IBA
10/2022
1Acute-Phase Proteins (Acute-Phase Protein)IBA
01/2022
1mesoglycanIBA
01/2022
1GlucocorticoidsIBA
01/2022
1Methotrexate (Mexate)FDA LinkGeneric
04/2021
1Synthetic DrugsIBA
03/2021
1Immunoglobulin D (IgD)IBA
03/2021
1belimumabIBA
01/2020
1Intergenic DNA (Junk DNA)IBA
12/2019
1AminopeptidasesIBA
12/2019
1Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA
11/2019
1Transfer RNA (tRNA)IBA
11/2019
1HLA Antigens (Human Leukocyte Antigens)IBA
11/2019
1Antirheumatic Agents (DMARD)IBA
11/2019
1Peptide Hydrolases (Proteases)FDA Link
01/2019
11,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA
03/2017
1Monoclonal AntibodiesIBA
03/2017
1InterleukinsIBA
01/2017
1CytokinesIBA
01/2017
1Rituximab (Mabthera)FDA Link
01/2017
1B-Cell Activating FactorIBA
01/2017
1anti-dsDNA autoantibodyIBA
07/2016
1EnzymesIBA
07/2016
1Abatacept (Orencia)FDA Link
01/2016
1MicroRNAs (MicroRNA)IBA
11/2015
1Adrenal Cortex Hormones (Corticosteroids)IBA
06/2015
1Interleukin-17 (Interleukin 17)IBA
01/2015
1KIR ReceptorsIBA
11/2014

Therapy/Procedure

6Therapeutics
04/2021 - 12/2004
1Precision Medicine
04/2021